Related Experiment Videos
Assays for recombinant proteins: a problem in non-linear calibration
1Biostatistics Department, Genetech, Inc., South San Francisco, CA 94080.
Statistics in Medicine
|June 15, 1994
Summary
This study introduces a non-linear mixed effects model framework for accurate protein quantification in biological samples. It highlights pooling assay data and using empirical Bayes methods for improved calibration curve fitting.
Area of Science:
- Biostatistics
- Bioassay
- Protein Quantification
Background:
- Protein quantification in biological matrices (serum, plasma) often uses immunoassays or bioassays.
- Accurate analyte concentration estimation relies on non-linear calibration curves fitted to known standards.
- Existing methods face challenges in characterizing intra-assay variation and optimizing calibration.
Purpose of the Study:
- To present a general framework for calibration inference using non-linear mixed effects models.
- To address accurate characterization of intra-assay variation in bioassays.
- To evaluate the utility of empirical Bayes methods for enhancing calibration efficiency.
Main Methods:
- Development of a non-linear mixed effects model framework for calibration.
- Analysis of intra-assay variability by pooling information across multiple assay runs.
- Application of empirical Bayes methods to improve calibration curve fitting.
- Illustration using a cell-based bioassay for recombinant human relaxin.
Main Results:
- Proper characterization of intra-assay variability necessitates pooling data from multiple assay runs.
- Empirical Bayes methods demonstrate potential for significant efficiency gains in calibration.
- Practical considerations for implementing Bayesian techniques must be weighed against efficiency gains.
Conclusions:
- Non-linear mixed effects models provide a robust framework for bioassay calibration.
- Pooling assay data is crucial for accurately assessing intra-assay variability.
- Empirical Bayes methods offer a promising approach to enhance calibration efficiency in bioassays, with implementation trade-offs to consider.